logo

For the Inventor, By the Inventor

Berlin, Germany

Hanns Ahrens

This inventor holds 8 USPTO granted patents. Top assignee: Schering Aktiengesellschaft. Active years: 1976-1977.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Hanns Ahrens. Retrieved from https://idiyas.com/inventor/hanns-ahrens

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 8

% Patents Active = 100.0

Average Co-Inventor Count = 6.1

ph-index = 4

Forward Citations = 106(Granted Patents)


Company Filing History:

goldMedal8 out of 1,409 
 
Schering Aktiengesellschaft
 patents

Years Active: 1976-1977

Loading Chart...
8 patents (USPTO):Explore Patents
1. 4058619 - Thiophene derivatives having antilipolytic activity (1977-11-15),
2. 4057640 - 5,6,7,8:Tetrahydrocarbazole-1-carboxylic acid derivatives (1977-11-08),
3. 4042706 - Novel anti-inflammatory pyrazole derivatives and preparation thereof (1977-08-16),
4. 4031236 - Novel thiophene derivatives and their preparation (1977-06-21),
5. 4021450 - Thiophene derivatives and their preparation (1977-05-03),
6. 3962471 - Indolylacetylamino acid derivatives, process for their preparation, and (1976-06-08),
7. 3960949 - 1,2-Biguanides (1976-06-01),
8. 3956295 - Carbazole derivatives (1976-05-11),

Title: **Hanns Ahrens: A Pioneer in Pharmaceutical Innovations**

Introduction

Hanns Ahrens is a distinguished inventor based in Berlin, Germany, known for his contributions to pharmaceutical innovations. With an impressive portfolio of eight patents, Ahrens has made significant advancements in the field of medicinal chemistry, particularly focusing on compounds with therapeutic effects.

Latest Patents

Ahrens' recent patents reflect his commitment to developing effective pharmaceutical agents. One notable patent includes his work on thiophene derivatives, which exhibit antilipolytic activity. These compounds are characterized by a specific formula where R_x and R_y are defined by various structural elements, promising potential applications in treating metabolic disorders. Another significant patent involves 5,6,7,8-tetrahydrocarbazole-1-carboxylic acid derivatives, which demonstrate topical anti-inflammatory properties. These inventions not only showcase his innovative approach but also have the potential to contribute meaningfully to patient care.

Career Highlights

Hanns Ahrens has a fruitful career associated with Schering Aktiengesellschaft, a leading pharmaceutical company. His role at the company has allowed him to focus on research and development in the realm of biological compounds, contributing to advancements in drug formulation and medicinal therapies.

Collaborations

Throughout his career, Ahrens has collaborated with notable scientists, including his colleagues Helmut Biere and Clemens Rufer. These collaborations have fostered a creative environment conducive to innovation, enabling the team to tackle complex pharmaceutical challenges together.

Conclusion

Hanns Ahrens stands out as an influential inventor in the pharmaceutical industry. His work not only reflects his expertise but also contributes to the broader field of medicinal science, paving the way for future innovations that may enhance therapeutic options for patients worldwide.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…